GSK 366 is a highly potent and selective inhibitor of kynurenine-3-monooxygenase (KMO), exhibiting IC50 values of 0.7 nM and 2.3 nM against the bacterial and human enzymes, respectively. This small molecule is a valuable research tool for investigating the kynurenine pathway in models of neurodegenerative and inflammatory diseases, both in vitro and in vivo.
Molecular Weight:
361.78
CAS Number:
[1953157-39-5]
Formula:
C17H16ClN3O4
Target:
Hydroxylase,Others
* VAT and and shipping costs not included. Errors and price changes excepted
